EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
De Rijdt, Thomas
Linked to EAHP Statements
Section 1 – Introductory Statements and Governance: Statements 1.2, 1.3
Section 3 – Production and Compounding: Statements 3.1, 3.2, 3.3, 3.4, 3.5
Section 5 – Patient Safety and Quality Assurance: Statements 5.2, 5.3, 5.9, 5.11
ACPE UAN: 0475-0000-21-015-L07-P. A knowledge-based activity.
Abstract
In 2016 the EU updated their resolution on quality and safety for medicinal products prepared in pharmacies, which defines the standards for the art of compounding. Just like the pharmaceutical industry has to comply with Eudralex GMP, the medication prepared in the hospital pharmacy must meet the requirements of Good Manufacturing Practices (GMP) or Good Preparation Practices (GPP), also known as PIC/S PE009-04 and PIC/S PE010-04. The goal of this resolution is to close the gap between pharmacy and industrial preparations and to lower the variation between the member states.
Therefore, hospital pharmacists started to invest in a better preparation environment but many of them underestimated the scope of a quality management system (QMS). It takes more than just a validated cleanroom with a high-tech air treatment system to deliver a quality product.
All steps in the processes should add to the quality and safety based on a risk assessment and a plan-do-check-act cycle (PDCA). The personnel must be adequately trained. The environmental parameters (temperature, humidity, pressure, number of particles, …) must be controlled. Follow-up on bioburden (air sampling, sedimentation plates, Rodac plates, …), operator skills (fingerprints, media fills, video training, …) and quality of the raw materials and final products is mandatory. And for batch productions a full product dossier is a requirement.
Besides the positive impact on the quality of the preparations, all these measures result in a higher operational cost and a longer lead time for this service. Therefore, hospitals must standardise their formularies and start to cooperate in networks to keep compounding cost-effective. All this requires prescribers to think and work differently. As not every personalised preparation is available on the fly. Other galenic formulations, dosebanding and standardized formularies might bring solace to guarantee better care. But how far can we go and when does one become a manufacturer instead of a compounding hospital pharmacist?
This seminar will focus on requirements, opportunities, limitations, affordability and on a pragmatic approach of GMP/GPP in a hospital pharmacy.
Learning objectives
After the session, participants should be able to:
• explain the requirements of GMP and GPP;
• describe the impact of a GMP/GPP quality management system on a hospital pharmacy;
• discuss the opportunities and limitations of GMP/GPP in the hospital pharmacy.
Education need addressed
Preparations in the hospital pharmacy must meet the high-quality standards of GMP/GPP. Therefore, the hospital pharmacist must understand the requirements and must be able to discuss the opportunities, limitations and the affordability for each hospital.
Keywords: GMP, GPP, quality management system, preparation, compounding, affordability, cost-effectiveness, standardization, dose-banding, hospital network, quality assurance, regulation.
